Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
World Neurosurg ; 180: e309-e316, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37769838

RESUMO

BACKGROUND: Low- and middle-income countries (LMICs) bear a heavier burden of neurosurgical diseases than high-income countries. Brazil, a growing middle-income country, holds promise as a health care market. However, there exists a lack of information to characterize the state of neurosurgical practice and access to care in Brazil. This study aimed to characterize neurosurgical practice in Brazil and identify barriers to care. METHODS: A collaborative survey was developed with Brazilian neurosurgeons and distributed by the Brazilian Society of Neurosurgery. The survey gathered demographic information, practice characteristics, case volume, referral patterns, income sources, and assessed barriers using a Likert scale. Descriptive statistics were employed for data analysis. RESULTS: One-hundred and forty-nine neurosurgeons participated (response rate: 17.5%), representing various states in Brazil. Neurosurgeons practiced in more than 4 different hospital systems on average, with most consultations and procedures occurring in public hospitals. Common procedures included tumor surgeries, general neurosurgery, spine surgeries, trauma surgeries, and hydrocephalus management. Equipment shortage and systemic issues were identified as major barriers to care. CONCLUSIONS: Neurosurgical practice in Brazil exhibits diverse age distribution, widespread distribution across states, and involvement in both public and private hospitals. Survey insights shed light on neurosurgical workload and neurosurgical practice characterization. Lack of equipment and inadequate postoperative resources pose significant barriers to care. The findings highlight the need for investments in equipment, critical care facilities, and improved health care system coordination to enhance access to neurosurgical care in Brazil.


Assuntos
Neurocirurgia , Humanos , Brasil , Países em Desenvolvimento , Procedimentos Neurocirúrgicos , Neurocirurgiões
2.
Epilepsy Behav ; 115: 107548, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33348195

RESUMO

Interictal dysphoric disorder (IDD) is a poorly understood psychiatric disorder of epilepsy patients. Interictal dysphoric disorder is characterized by depressive, somatoform, and affective symptoms observed in up to 5.9% of drug-resistant mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). This study aimed to evaluate the association between ictal fear (IF) and the psychiatric symptoms and diagnosis in MTLE-HS patients. We included 116 (54.3% male) consecutive adult patients (36 ±â€¯11 years) with MTLE-HS. Anxiety and depression symptoms were evaluated by the Hospital Anxiety and Depression Scale (HADS) and the psychiatric diagnosis were according to Fourth Edition of the Diagnosis and Statistical Manual of Mental Disorders (DSM-IV). The independent association between the occurrence of IF aura and the psychiatric diagnosis was determined by binary regression. When compared to those with other auras or without aura, patients reporting IF have higher HADS anxiety, but not HADS depression, scores. Ictal fear was independently associated with the diagnosis of interictal dysphoric disorder (OR, IC 95% = 7.6, 1.3-43.2, p = 0.02), but not with the diagnosis of anxiety (OR, CI 95% = 0.72, 0.08-6.0, p = 0.73), depression (OR, CI 95% = 0.94, 0.19-4.8, p = 0.94) or psychotic disorders (p = 0.99). Only patients with drug-resistant MTLE-HS were included and the small number of cases with DD diagnosis in the sample. In MTLE-HS patients, the occurrence of IF is associated with higher levels of anxiety symptoms and IDD. The results provide insights about fear-related neural network connections with anxiety symptoms and the IDD in MTLE-HS.


Assuntos
Epilepsia Resistente a Medicamentos , Epilepsia do Lobo Temporal , Preparações Farmacêuticas , Adulto , Ansiedade/etiologia , Epilepsia Resistente a Medicamentos/complicações , Epilepsia Resistente a Medicamentos/patologia , Epilepsia do Lobo Temporal/complicações , Epilepsia do Lobo Temporal/patologia , Medo , Feminino , Hipocampo/patologia , Humanos , Masculino , Esclerose/patologia
3.
Epilepsy Behav ; 112: 107453, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33181899

RESUMO

OBJECTIVE: The objective of the study was to investigate the independent association between clinical, demographic, psychiatric, radiologic, electrophysiological, and pharmacologic variables and cognitive performance of Brazilian patients with pharmacoresistant mesial temporal lobe epilepsy (MTLE). METHODS: Ninety-three patients with pharmacoresistant MTLE related to hippocampal sclerosis (HS) were included in the study. Multiple linear regressions were done to identify predictor variables for 24 cognitive tests. Independent variables analyzed were sex, hand dominance, age, years of education, marital status, work activity, history for an initial precipitant injury (IPI), family history of epilepsy, lesion side, antiseizure medication (ASM) treatment type, ASM serum levels, benzodiazepine (BDZ) treatment, age at epilepsy onset, disease duration, monthly frequency of seizures, and Hospital Anxiety and Depression Scale (HADS) scores. RESULTS: Years of education was an independent and positive predictor in 22 of the 24 cognitive tests evaluated. Male sex was also a positive predictor of one cognitive test. Variables negatively associated with cognitive performance were left side lesion (10 tests), disease duration (5 tests), polytherapy (3 tests), ASM serum levels (3 tests), and BDZ treatment or not working (1 test each). The regression model explained between 6% and 44% of the cognitive test scores variation. SIGNIFICANCE: In Brazilian patients with pharmacoresistant MTLE-HS, up to 44% of cognitive test scores variation is predictable by clinical, demographic, psychiatric, radiologic, electrophysiology, and pharmacological variables. The identification of predictors of cognitive performance may be helpful for better planning of patient care.


Assuntos
Epilepsia do Lobo Temporal , Brasil , Cognição , Epilepsia do Lobo Temporal/complicações , Epilepsia do Lobo Temporal/tratamento farmacológico , Epilepsia do Lobo Temporal/patologia , Hipocampo/patologia , Humanos , Masculino , Esclerose/patologia
4.
Front Neurosci ; 13: 958, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31619946

RESUMO

INTRODUCTION: Facet joint injections (FJIs) of anesthetic and corticosteroids are useful for the diagnosis and treatment of low back pain (LBP). In the current study, we evaluated the efficacy of FJI on LBP treatment and the predictive variables of pain recurrence after FJI. METHODS: We included and followed prospectively forty-three consecutive patients with chronic LBP treated with FJI. Clinical assessments were carried out at a baseline 1 week before FJIs and after a 6-month follow-up visit using the visual analog scale (VAS) for pain, Oswestry Disability Index (ODI) for disability-specific measure and MacNab criteria for global effectiveness, and compared through analysis using paired-samples "t" tests. Multiple cox-regression analysis was used to identify the presurgical variables independently associated with pain recurrence anytime during the follow-up. In addition to the demographic, clinical, and surgical data, we also analyzed psychometric scales: Pain Catastrophizing Scale (PCS), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI). RESULTS: After a 6-month follow-up, thirty-two patients (74.4%) showed a clinically significant reduction of pain and twenty-seven (62.8%) reported a clinically significant improvement of disability. Presurgical catastrophizing (PCS score ≥ 5, adjusted HR 4.4, CI 95% 1.7-11.3, p = 0.002) and smoking (Adjusted HR 12.5, CI 95% 1.1-138.9, p = 0.04) remains associated with pain recurrence. CONCLUSION: FJI reduces LBP and disability of patients with unresponsive LBP. Pain-related cognitive and behavioral factors determined by pain catastrophizing and smoking were independently associated with pain recurrence after lumbar FJI. The results support the need of a multidisciplinary approach for presurgical evaluation of patients with chronic pain.

5.
Neuromodulation ; 22(3): 280-289, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30536545

RESUMO

OBJECTIVES: Previous studies demonstrated significant improvement in mean pain scores and quality of life (QOL) scales in patients with chronic pain who underwent spinal cord stimulation (SCS). However, the number of individuals who experience relevant improvements in QOL, termed the meaningful clinical improvement (MCI), is not known. The present study investigated changes in pain measurements based on MCI after SCS. MATERIALS AND METHODS: Thirty-four patients with chronic intractable pain completed scales of pain (visual analogue scale [VAS]), QOL (SF-36), and psychological dimensions during a 22-month follow-up period (mean). Patient-centered MCI of the VAS and SF-36 domain scores were determined based on the MacNab criteria of surgical global effectiveness. Independent presurgical predictors for MCI in the VAS and SF-36 domains were analyzed using multiple binary logistic regression. RESULTS: There was significant improvement of pain and QOL after the SCS (p < 0.00001). Twenty-three patients (67.6%) reached an MCI of pain, and 16 (47.7%)-23 (67.7%) reported an MCI of QOL. Predictors of MCI included ≥80% paresthesia coverage of the painful area, lower levels of anxiety and catastrophizing symptoms, shorter pain duration, female gender and no use of opioids before surgery. MCI of pain and QOL was observed in 50%-70% of patients with chronic pain after SCS. CONCLUSIONS: The identification of determinants for MCI is a challenge to improve the accuracy of prognostic models in SCS for patients with chronic pain. Our results, if confirmed in other populations with a larger sample size, have implications for patients with chronic pain who are candidates for SCS treatment.


Assuntos
Dor Crônica/terapia , Medição da Dor/tendências , Dor Intratável/terapia , Qualidade de Vida , Estimulação da Medula Espinal/tendências , Adulto , Idoso , Dor Crônica/diagnóstico , Dor Crônica/psicologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Medição da Dor/psicologia , Dor Intratável/diagnóstico , Dor Intratável/psicologia , Valor Preditivo dos Testes , Qualidade de Vida/psicologia , Estimulação da Medula Espinal/psicologia , Resultado do Tratamento
6.
Mov Disord ; 27(12): 1559-63, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23038611

RESUMO

BACKGROUND: Thalamotomies and pallidotomies were commonly performed before the deep brain stimulation (DBS) era. Although ablative procedures can lead to significant dystonia improvement, longer periods of analysis reveal disease progression and functional deterioration. Today, the same patients seek additional treatment possibilities. METHODS: Four patients with generalized dystonia who previously had undergone bilateral pallidotomy came to our service seeking additional treatment because of dystonic symptom progression. Bilateral subthalamic nucleus DBS (B-STN-DBS) was the treatment of choice. The patients were evaluated with the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the Unified Dystonia Rating Scale (UDRS) before and 2 years after surgery. RESULTS: All patients showed significant functional improvement, averaging 65.3% in BFMDRS (P = .014) and 69.2% in UDRS (P = .025). CONCLUSIONS: These results suggest that B-STN-DBS may be an interesting treatment option for generalized dystonia, even for patients who have already undergone bilateral pallidotomy.


Assuntos
Estimulação Encefálica Profunda/métodos , Distúrbios Distônicos/terapia , Palidotomia/métodos , Núcleo Subtalâmico/fisiologia , Adulto , Feminino , Lateralidade Funcional , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Adulto Jovem
7.
Case Rep Neurol Med ; 2012: 367304, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22937350

RESUMO

We presented a case of drug-resistant trigeminal neuralgia attributed to vertebrobasilar dolichoectasia, a rare condition characterized by enlargement, tortuosity, or elongation of intracranial arteries. Dolichoectatic vessels can cause dysfunction of cranial nerves through direct vascular compression. The relationships of vertebrobasilar dolichoectasia with the particularities of neurovascular conflict and images findings are discussed.

8.
Arq. bras. neurocir ; 30(4)dez. 2011. ilus, tab
Artigo em Português | LILACS | ID: lil-614351

RESUMO

Spinal intradural arteriovenous fistulas (AVFs) are a rare type of neurovascular malformation. Many a time hemodynamic disturbs associated to these entities can cause edema with subsequent myelopathy. On MRI study, this edema can mimic an intramedullary tumor. We report a rare case of spinal intradural AVFs mimicking an intramedullary tumor, which also were surprisingly associated with a giant intracranial aneurysm. We highlight in detail the MRI findings in intramedullary lesions, and also emphasize that these entities requires as careful differential diagnosis as supplementary investigation of the neuroaxis looking for other simultaneous neurovascular pathologies.


Fístulas arteriovenosas espinhais intradurais são um tipo raro de malformação neurovascular. Muitas vezes, distúrbios hemodinâmicos associados a essa entidade podem causar edema com subsequente mielopatia. Em estudos de ressonância magnética, esse edema pode mimetizar um tumor intramedular. Relata-se um caso raro de fistula arteriovenosa espinhal intradural mimetizando um tumor intramedular, que também estava associado a um aneurisma cerebral gigante. Destacam-se em detalhes os achados de RM nas lesões intramedulares, assim como se enfatiza que essas entidades requerem tanto um diagnóstico diferencial criterioso quanto uma investigação complementar do neuroeixo procurando por outras patologias neurovasculares associadas.


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Aneurisma Intracraniano/complicações , Fístula Arteriovenosa/diagnóstico , Neoplasias da Medula Espinal/complicações , Coluna Vertebral/patologia , Medula Espinal/patologia
9.
Arq. bras. neurocir ; 30(2)jun. 2011. ilus
Artigo em Português | LILACS | ID: lil-604904

RESUMO

O infarto cerebral hemisférico maligno tem mortalidade de 80%, apesar do tratamento conservador. Ele representa infarto de mais de 50% do território da artéria cerebral média (ACM), entretanto, nem todos os pacientes irão desenvolver o curso maligno. O objetivo desta revisão foi encontrar os fatores preditivos do curso maligno do edema cerebral maligno e, a partir desses fatores, propor um algoritmo de tratamento e tomadas de decisões para o infarto cerebral hemisférico. Os preditores foram pesquisados em artigos no PubMed. Com base nos preditores encontrados com valor estatístico significativo, estruturou-se um algoritmo de gerenciamento para o infarto cerebral hemisférico. Os fatores preditivos de curso maligno foram: NIHSS > 15 hemisfério dominante e > 20 não dominante; oclusão da artéria carótida interna (ACI) ipsilateral à malformação do círculo de Willis; circulação colateral deficiente; tomografia computadorizada (TC) hipodensidade > 50% e ressonância magnética (RM) difusão > 145 cm3 do território da ACM; outro território vascular envolvido; perda da autorregulação; potencial evocado auditivo patológico; pressão intracraniana (PIC) > 35 mmHg e valores de pico de aminoácidos excitatórios medidos na microdiálise. Entretanto, esses dois últimos fatores aparecem apenas depois que o paciente está herniado. Os trials europeus definiram nível de evidência 1 para craniectomia descompressiva. Craniectomia descompressiva é o tratamento de primeira escolha para os pacientes < 60 anos com curso maligno do infarto hemisférico < 48h. Os fatores preditivos são importantes ferramentas para tomada de decisão quanto à indicação cirúrgica precoce.


Massive hemispheric infarctions (MHI) constitute 10% of all ischemic strokes and have a mortality rate of 80%, under conservative treatment. This stroke presents a hypodensity covering more than 50% of the middle cerebral artery (MCA) territory, however, not all the patients develop the malignant course of hemispheric infarctions. The goal of this study was to determine the predictors of fatal brain edema and to propose an evidence-based management algorithm. Search for predictors of MHI with malignant edema was performed in PubMed and Cochrane data base. An evidence-based management algorithm was structured from this study. Different predictors of fatal brain edema formation have been identified: NIHSS > 15 dominant and > 20 non dominant hemisphere; carotid occlusion with abnormal ipsilateral circle of Willis; collateral deficit; early computed tomography (CT) hypodensity involving > 50% or DWI > 145 cm3 of the MCA territory; involvement of additional vascular territories; impaired cerebral autoregulation; pathological auditory potentials evoked; ICP > 35 mmHg; microdialysis with peak values of the excitatory amino acids. Decompressive hemicraniectomy is the first choice to treatment for MHI with malignant brain edema in patients > 60 years and < 48 hours after stroke. To know predictors with evidence level are important tools to make decision about surgical indication.


Assuntos
Humanos , Craniectomia Descompressiva , Infarto da Artéria Cerebral Média/terapia
10.
Arq Neuropsiquiatr ; 69(2A): 221-6, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21537565

RESUMO

OBJECTIVE: Trigeminal neuralgia is the most common facial pain. It may be treated with percutaneous balloon compression (PBC), which is considered to be a safe and efficient procedure. The purpose of this study was to review our results with PBC and to assess the factors influencing the outcome. METHOD: A multivariate analysis was used to study 39 patients during a 50-month postoperative period. RESULTS: There was predominance of the female gender (54%), the right side of the face (84%) and V2V3 roots of trigeminal nerve (33%). The mean age was 62.3 years. No major complications or deaths occurred. Among all variables, postoperative hypoesthesia was the single prognostic factor capable of positively influencing the results (p=0.02). Most patients (80%) were pain-free after 50 months with a 90% satisfaction rate. CONCLUSION: PBC was a safe procedure with low morbidity, no mortality, high approval ratings, and was an important improving on patients' quality of life.


Assuntos
Cateterismo/métodos , Neuralgia do Trigêmeo/terapia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Pressão , Estudos Prospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA